Evaluate muscle mass when setting target body weight

Yutaka Seino received honoraria for lectures from Sumitomo Pharma Co., Novo Nordisk Pharma Ltd, Taisho Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., and Mitsubishi Tanabe Pharma Corporation. Hitoshi Kuwata received grants from Ono Pharmaceutical Co., Taisho Pharmaceutical Co., and Novo Nordisk Pharma Ltd; and honoraria for lectures from Sanofi K.K., and Taisho Pharmaceutical Co. Yutaka Seino has received grants from Nippon Boehringer Ingelheim Co., Ltd, ARKRAY Marketing, Inc., Taisho Pharmaceutical Co., Ltd, Novo Nordisk Pharma Ltd, Terumo Corporation, and Sumitomo Pharma Co.; and honoraria for lectures from Taisho Pharmaceutical Co., Ltd, Nippon Becton Dickinson Company, Ltd, Novo Nordisk Pharma Ltd, Eli Lilly Japan K.K., Sumitomo Pharma Co., Ltd, and Ono Pharmaceutical Co., Ltd. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70218. All datasets presented in this manuscript are not publicly available but are available from the corresponding author on reasonable request. The resources are available on request.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-10-20
DOI
https://doi.org/10.1111/dom.70218
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluate muscle mass when setting target body weight

Yutaka Seino, Yuji Yamazaki, Hitoshi Kuwata, Mari Matsushiro
Diabetes Obesity and Metabolism
Diet and metabolism studies
article

Evaluate muscle mass when setting target body weight

Yutaka Seino, Yuji Yamazaki, Hitoshi Kuwata, Mari Matsushiro
article en

Abstract

Yutaka Seino received honoraria for lectures from Sumitomo Pharma Co., Novo Nordisk Pharma Ltd, Taisho Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., and Mitsubishi Tanabe Pharma Corporation. Hitoshi Kuwata received grants from Ono Pharmaceutical Co., Taisho Pharmaceutical Co., and Novo Nordisk Pharma Ltd; and honoraria for lectures from Sanofi K.K., and Taisho Pharmaceutical Co. Yutaka Seino has received grants from Nippon Boehringer Ingelheim Co., Ltd, ARKRAY Marketing, Inc., Taisho Pharmaceutical Co., Ltd, Novo Nordisk Pharma Ltd, Terumo Corporation, and Sumitomo Pharma Co.; and honoraria for lectures from Taisho Pharmaceutical Co., Ltd, Nippon Becton Dickinson Company, Ltd, Novo Nordisk Pharma Ltd, Eli Lilly Japan K.K., Sumitomo Pharma Co., Ltd, and Ono Pharmaceutical Co., Ltd. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70218. All datasets presented in this manuscript are not publicly available but are available from the corresponding author on reasonable request. The resources are available on request.

Diabetes Obesity and MetabolismVol. 28(1)
Kansai Electric Power Hospital (JP)
Openalex Percentile: Top 63%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.